510(k) · Orthopedic

Precision AI Surgical Planning System (PAI-SPS)

by Precision AI Pty, Ltd.

Precision AI Surgical Planning System (PAI-SPS) is an AI-enabled medical device from Precision AI Pty, Ltd. that the U.S. FDA cleared through 510(k) K251558 on January 12, 2026. Its lead review panel is Orthopedic and its primary product code is QHE (Shoulder Arthroplasty Implantation System).

See also all FDA AI clearances in 2026.

Key facts

Submission numberK251558
Pathway510(k)
Date of final decision
Company (FDA list)Precision AI Pty, Ltd.
Lead review panelOrthopedic
Primary product codeQHE — Shoulder Arthroplasty Implantation System
Applicant (openFDA)Precision AI Pty, Ltd.
Applicant locationFortitude Valley, AU
Device classClass 2
Regulation number21 CFR 888.3660
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. Precision AI Surgical Planning System (PAI-SPS) went through this pathway (K251558).

openFDA lists it as a Class 2 device under 21 CFR 888.3660. Class II devices are moderate risk and are subject to general and special controls.

Product code QHE covers 4 devices on the FDA AI list. By decision date, this device is #3 of 4 under that code. Precision AI Pty, Ltd. has 3 AI-enabled devices on the list, and the Orthopedic panel accounts for 8 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code QHE)

More from Precision AI Pty, Ltd.